Inherited variation in circadian rhythm genes and risks of prostate cancer and three other cancer sites in combined cancer consortia

被引:32
作者
Gu, Fangyi [1 ,2 ]
Zhang, Han [1 ]
Hyland, Paula L. [1 ]
Berndt, Sonja [1 ]
Gapstur, Susan M. [3 ]
Wheeler, William [4 ]
Amos, Christopher I. [5 ]
Bezieau, Stephane [6 ]
Bickeboller, Heike [7 ]
Brenner, Hermann [8 ,9 ,10 ,11 ]
Brennan, Paul [12 ]
Chang-Claude, Jenny [13 ]
Conti, David V. [14 ]
Doherty, Jennifer Anne [15 ]
Gruber, Stephen B. [14 ]
Harrison, Tabitha A. [16 ]
Hayes, Richard B. [17 ]
Hoffmeister, Michael [8 ]
Houlston, Richard S. [18 ]
Hung, Rayjean J. [19 ]
Jenkins, Mark A. [20 ]
Kraft, Peter [21 ]
Lawrenson, Kate [22 ]
Mckay, James [12 ]
Markt, Sarah [21 ]
Mucci, Lorelei [21 ]
Phelan, Catherine M. [23 ]
Qu, Conghui [16 ]
Risch, Angela [24 ,25 ,26 ,27 ,28 ]
Rossing, Mary Anne [16 ]
Wichmann, H. -Erich [29 ,30 ,31 ]
Shi, Jianxin [1 ]
Schernhammer, Eva [21 ,32 ,33 ]
Yu, Kai [1 ]
Landi, Maria Teresa [1 ]
Caporaso, Neil E. [1 ]
机构
[1] NCI, Div Canc Epidemiol & Genet, Rockville, MD USA
[2] Roswell Pk Canc Inst, Dept Canc Prevent & Control, Buffalo, NY 14263 USA
[3] Amer Canc Soc, Epidemiol Res Program, Atlanta, GA 30329 USA
[4] Informat Management Serv Inc, Rockville, MD USA
[5] Geisel Dartmouth Med Sch, Lebanon, NH USA
[6] CHU Nantes, Serv Gertet Med, Nantes, France
[7] Univ Med Ctr Gottingen, Dept Genet Epidemiol, Gottingen, Germany
[8] German Canc Res Ctr, Div Clin Epidemiol & Aging Res, Heidelberg, Germany
[9] Natl Ctr Tumor Dis NCI, Div Prevent Oncol, Heidelberg, Germany
[10] German Canc Res Ctr, Heidelberg, Germany
[11] German Canc Res Ctr, German Canc Consortium DKTK, Heidelberg, Germany
[12] Int Agcy Res Canc, Lyon, France
[13] German Canc Res Ctr, Div Canc Epidemiol, Heidelberg, Germany
[14] Univ South Calif, Keck Sch Med, Los Angeles, CA USA
[15] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT USA
[16] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, 1124 Columbia St, Seattle, WA 98104 USA
[17] NYU, Sch Med, Dept Popubat Hlth, New York, NY USA
[18] Inst Canc Res, Div Genet & Epidemiol, Sutton, Surrey, England
[19] Sinai Hlth Syst, Lunenfeld Tanenbaum Res Inst, Toronto, ON, Canada
[20] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Ctr Epidemiol & Biostat, Parkville, Vic, Australia
[21] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA
[22] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA
[23] H Lee Moffitt Canc Ctr & Res Inst, Div Populat Sci, Dept Canc Epidemiol, Tampa, FL USA
[24] Univ Salzburg, Div Mol Biol, Salzburg, Austria
[25] Canc Cluster Sarzburg, Salzburg, Austria
[26] Translat Lung Res Ctr, Heidelberg, Germany
[27] German Ctr Lung Res DZL, Giessen, Germany
[28] DKFZ German Canc Res Ctr, Div Epigen & Canc Risk Factors, Leidelberg, Germany
[29] Univ Munich, Inst Med Informat Biometry & Epidemiol, Munich, Bavaria, Germany
[30] Helmholtz Ctr Munich, Inst Epidemiol 2, Neuherberg, Germany
[31] Tech Univ Munich, Inst Med Stat & Epidemiol, Munich, Germany
[32] Harvard Med Sch, Brigham & Womens Hosp, Channing Div Network Med, Boston, MA USA
[33] Med Univ Vienna, Dept Epidemiol, Vienna, Austria
基金
瑞典研究理事会; 美国国家卫生研究院; 英国医学研究理事会; 加拿大健康研究院;
关键词
circadian rhythm; melatonin; prostate cancer; cancer; GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY LOCI; DNA-DAMAGE; SHIFT-WORK; CELL-PROLIFERATION; COLORECTAL-CANCER; LUNG-CANCER; NIGHT WORK; CLOCK; MELATONIN;
D O I
10.1002/ijc.30883
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Circadian disruption has been linked to carcinogenesis in animal models, but the evidence in humans is inconclusive. Genetic variation in circadian rhythm genes provides a tool to investigate such associations. We examined associations of genetic variation in nine core circadian rhythm genes and six melatonin pathway genes with risk of colorectal, lung, ovarian and prostate cancers using data from the Genetic Associations and Mechanisms in Oncology (GAME-ON) network. The major results for prostate cancer were replicated in the Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening trial, and for colorectal cancer in the Genetics and Epidemiology of Colorectal Cancer Consortium (GECCO). The total number of cancer cases and controls was 15,838/18,159 for colorectal, 14,818/14,227 for prostate, 12,537/17,285 for lung and 4,369/9,123 for ovary. For each cancer site, we conducted gene-based and pathway-based analyses by applying the summary-based Adaptive Rank Truncated Product method (sARTP) on the summary association statistics for each SNP within the candidate gene regions. Aggregate genetic variation in circadian rhythm and melatonin pathways were significantly associated with the risk of prostate cancer in data combining GAME-ON and PLCO, after Bonferroni correction (rho(pathway) < 0.00625). The two most significant genes were NPAS2 (rho(gene) = 0.0062) and AANAT (rho(gene) = 0.00078); the latter being significant after Bonferroni correction. For colorectal cancer, we observed a suggestive association with the circadian rhythm pathway in GAME-ON (peat,way = 0.021); this association was not confirmed in GECCO (rho(pathway) = 0.76) or the combined data In (rho(pathway) = 0.17). No significant association was observed for ovarian and lung cancer. These findings support a potential role for circadian rhythm and melatonin pathways in prostate carcinogenesis. Further functional studies are needed to better understand the underlying biologic mechanisms.
引用
收藏
页码:1794 / 1802
页数:9
相关论文
共 50 条
  • [31] Genetic variation in microRNA genes and prostate cancer risk in North Indian population
    Ginu P. George
    Ruchika Gangwar
    Raju K. Mandal
    Satya N. Sankhwar
    Rama D. Mittal
    Molecular Biology Reports, 2011, 38 : 1609 - 1615
  • [32] Cancer risks for other sites in addition to breast in CHEK2 c.1100delC families
    Schreurs, Maartje A. C.
    Schmidt, Marjanka K.
    Hollestelle, Antoinette
    Schaapveld, Michael
    van Asperen, Christi J.
    Ausems, Margreet G. E. M.
    van de Beek, Irma
    Broekema, Marjoleine F.
    Collee, J. Margriet
    van der Hout, Annemieke H.
    van Kaam, Kim J. A. F.
    Komdeur, Fenne L.
    Mensenkamp, Arjen R.
    Adank, Muriel A.
    Hooning, Maartje J.
    GENETICS IN MEDICINE, 2024, 26 (09)
  • [33] Performance of Three Inherited Risk Measures for Predicting Prostate Cancer Incidence and Mortality: A Population-based Prospective Analysis
    Shi, Zhuqing
    Platz, Elizabeth A.
    Wei, Jun
    Na, Rong
    Fantus, Richard J.
    Wang, Chi-Hsiung
    Eggener, Scott E.
    Hulick, Peter J.
    Duggan, David
    Zheng, S. Lilly
    Cooney, Kathleen A.
    Isaacs, William B.
    Helfand, Brian T.
    Xu, Jianfeng
    EUROPEAN UROLOGY, 2021, 79 (03) : 419 - 426
  • [34] Identification of potential susceptibility loci for non-small cell lung cancer through whole genome sequencing in circadian rhythm genes
    Xu, Xiaohang
    Xu, Luopiao
    Lang, Zeyong
    Sun, Gege
    Pan, Junlong
    Li, Xue
    Bian, Zilong
    Wu, Xifeng
    SCIENTIFIC REPORTS, 2025, 15 (01):
  • [35] Expression pattern of circadian rhythm-related genes and its potential relationship with miRNAs activity in endometrial cancer
    Hermyt, Ewelina
    Zmarzly, Nikola
    Kruszniewska-Rajs, Celina
    Gola, Joanna
    Jeda-Golonka, Agnieszka
    Szczepanek, Katarzyna
    Mazurek, Urszula
    Witek, Andrzej
    GINEKOLOGIA POLSKA, 2023, 94 (01) : 33 - 40
  • [36] Gene therapy of prostate cancer: P53, suicidal genes, and other targets
    Boulikas, T
    ANTICANCER RESEARCH, 1997, 17 (3A) : 1471 - 1505
  • [37] A Custom Genotyping Array Reveals Population-Level Heterogeneity for the Genetic Risks of Prostate Cancer and Other Cancers in Africa
    Harlemon, Maxine
    Ajayi, Olabode
    Kachambwa, Paidamoyo
    Kim, Michelle S.
    Simonti, Corinne N.
    Quiver, Melanie H.
    Petersen, Desiree C.
    Mittal, Anuradha
    Fernandez, Pedro W.
    Hsing, Ann W.
    Baichoo, Shakuntala
    Agalliu, Ilir
    Jalloh, Mohamed
    Gueye, Serigne M.
    Snyper, Nana Yaa F.
    Adusei, Ben
    Mensah, James E.
    Abrahams, Afua O. D.
    Adebiyi, Akindele O.
    Orunmuyi, Akin T.
    Aisuodionoe-Shadrach, Oseremen I.
    Nwegbu, Maxwell M.
    Joffe, Maureen
    Chen, Wenlong C.
    Irusen, Hayley
    Neugut, Alfred I.
    Quintana, Yuri
    Seutloali, Moleboheng
    Fadipe, Mayowa B.
    Warren, Christopher
    Woehrmann, Marcos H.
    Zhang, Peng
    Ongaco, Chrissie M.
    Mawhinney, Michelle
    McBride, Jo
    Andrews, Caroline V.
    Adams, Marcia
    Pugh, Elizabeth
    Rebbeck, Timothy R.
    Petersen, Lindsay N.
    Lachance, Joseph
    CANCER RESEARCH, 2020, 80 (13) : 2956 - 2966
  • [38] Correlation between circadian rhythm related genes, type 2 diabetes, and cancer: Insights from metanalysis of transcriptomics data
    Barbosa Vieira, Thaysa Kelly
    da Rocha Leao, Myra Jurema
    Pereira, Luciana Xavier
    Alves da Silva, Laryssa Cristina
    Pereira da Paz, Bruno Batista
    Santos Ferreira, Ricardo Jansen
    Feitoza, Christiane Cavalcante
    Duarte, Ana Kelly Fernandes
    Barros Ferreira Rodrigues, Amanda Karine
    de Queiroz, Aline Cavalcanti
    de Farias, Karol Fireman
    Koike, Bruna Del Vechio
    Marques, Carolinne de Sales
    de Carvalho Fraga, Carlos Alberto
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2021, 526
  • [39] Genetic variation in nucleotide excision repair pathway genes, pesticide exposure and prostate cancer risk
    Barry, Kathryn Hughes
    Koutros, Stella
    Andreotti, Gabriella
    Sandler, Dale P.
    Burdette, Laurie A.
    Yeager, Meredith
    Freeman, Laura E. Beane
    Lubin, Jay H.
    Ma, Xiaomei
    Zheng, Tongzhang
    Alavanja, Michael C. R.
    Berndt, Sonja I.
    CARCINOGENESIS, 2012, 33 (02) : 331 - 337
  • [40] Inherited Variants in Wnt Pathway Genes Influence Outcomes of Prostate Cancer Patients Receiving Androgen Deprivation Therapy
    Geng, Jiun-Hung
    Lin, Victor C.
    Yu, Chia-Cheng
    Huang, Chao-Yuan
    Yin, Hsin-Ling
    Chang, Ta-Yuan
    Lu, Te-Ling
    Huang, Shu-Pin
    Bao, Bo-Ying
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2016, 17 (12):